Significant Ownership of Woodline Partners LP

Signature - Title
/s/ Erin Mullen - Erin Mullen, General Counsel & Chief Compliance Officer
Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Woodline Partners LP.

Notify me when Woodline Partners LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Woodline Partners LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SABS SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% $14,293,092 7,125,881 Woodline Partners LP 30 Sep 2025
ALGS Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share 8.7% $4,607,078 -$492,994 468,199 -9.7% Woodline Partners LP 30 Sep 2025
AIRO AIRO Group Holdings, Inc. Common Stock, par value $0.000001 per share 8.5% $52,858,886 +$15,368,755 2,753,067 +41% Woodline Partners LP 30 Sep 2025
OM Outset Medical, Inc. Common Stock, par value $0.001 per share 7.5% $13,469,965 1,325,784 Woodline Partners LP 31 Mar 2025
PLRX PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 7.3% $6,667,129 4,504,817 Woodline Partners LP 30 Sep 2025
ZVRA ZEVRA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 6.2% $33,058,120 3,476,143 Woodline Partners LP 30 Sep 2025
EQ Equillium, Inc. Common Stock, par value $0.0001 per share 5.9% $5,017,192 3,508,771 Woodline Partners LP 30 Sep 2025
TNGX Tango Therapeutics, Inc. Common Stock, par value $0.001 per share 5.6% $41,606,351 6,029,906 Woodline Partners LP 30 Jun 2025
VSH VISHAY INTERTECHNOLOGY INC Common Stock, par value $0.10 per share 5.5% $104,250,604 6,813,765 Woodline Partners LP 30 Sep 2025
TNYA Tenaya Therapeutics, Inc. Common Stock, par value $0.0001 per share 5% $10,170,000 +$3,484,731 9,000,000 +52% Woodline Partners LP 30 Jun 2025
SGMT Sagimet Biosciences Inc. Series A Common Stock, par value $0.0001 per share 4.8% $10,299,309 -$7,211,088 1,501,357 -41% Woodline Partners LP 30 Sep 2025
GRDN Guardian Pharmacy Services, Inc. Class A Common Stock, par value $0.001 per share 4.5% $9,493,794 415,120 Woodline Partners LP 31 Dec 2024
TARA Protara Therapeutics, Inc. Common Stock, par value $0.001 per share 3.9% $5,191,906 1,331,258 Woodline Partners LP 31 Dec 2024
TVTX Travere Therapeutics, Inc. Common Stock, par value $0.0001 per share 2.4% $28,518,615 2,114,056 Woodline Partners LP 31 Dec 2024

Schedules 13D/G Reported by Woodline Partners LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.